.Considering that the concern is entirely an OFS, the provider will definitely certainly not receive any proceeds plus all the funds will certainly visit the offering investors (Image: Shutterstock) 2 minutes checked out Final Updated: Oct 07 2024|5:52 PM IST.Integrated diagnostic chain Suraksha Diagnostic Ltd has gotten Sebi's go ahead to raise funds via a going public (IPO), an update along with the marketplaces regulatory authority presented on Monday.The Kolkata-headquartered provider's proposed IPO features an Offer-for-Sale (OFS) of approximately 1.92 crore equity allotments by promoters as well as financier shareholders, without any new concern element, depending on to the Draft Wild-goose Chase Syllabus (DRHP). Click here to get in touch with us on WhatsApp.Under the OFS, marketers-- Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma as well as capitalists-- OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal and also Santosh Kumar Kejriwal will certainly unload allotments..The provider, which had actually filed preliminary IPO papers in July, acquired the regulator's observation on September 30, the update showed.In Sebi's argot, securing its own reviews means the regulatory authority's go on to float the public issue.Based on the draft documents, the provider will certainly certainly not receive any kind of proceeds and all the funds will definitely go to the offering investors as the concern is actually entirely an OFS.Explaining the factor for going social, the provider, in its receipt documents, explained that the listing is aimed at attaining the benefit of specifying equity reveals on the stock market and carrying out OFS for the offering investors.Due to the fact that the problem is completely an OFS, the firm is going to not receive any kind of proceeds plus all the funds will definitely go to the selling investors.Suraksha Diagnostic uses a one-stop integrated solution for pathology and radiology testing as well as medical appointment services to its own consumers with its significant working system, containing a front runner core recommendation laboratory, 8 gps labs and 194 customer touchpoints which include 48 diagnostic facilities, and also 146 example collection centres (primarily franchised), around West Bengal, Bihar, Assam and also Meghalaya as of March 31, 2024.During the course of monetary 2024, it performed regarding 5.98 thousand tests providing approximately 1.14 million patients.ICICI Stocks Ltd, Nuvama Wealth Administration Ltd and also SBI Financing Markets Ltd are the book-running lead managers to the problem. The equity shares are actually recommended to become specified on BSE and NSE.( Only the headline as well as photo of this report may possess been modified due to the Company Specification personnel the remainder of the information is auto-generated from a syndicated feed.) Initial Published: Oct 07 2024|5:52 PM IST.